filmov
tv
Novel Strategies to Accelerate Discovery of Translatable Therapeutic Targets
Показать описание
WuXi Discovery Services
Рекомендации по теме
1:00:49
Novel Strategies to Accelerate Discovery of Translatable Therapeutic Targets
0:13:50
Michela Mazzon (UCL): Accelerating discovery in antivirals, vaccines & diagnostics
0:02:10
FMC ($FMC) and Optibrium Partner to Accelerate Discovery of Novel Crop Protections Through A.I.
0:04:15
How AI is accelerating drug discovery - Nature's Building Blocks | BBC StoryWorks
0:22:58
Novel Strategies for Discovery of Cardiovascular Biomarkers in Human Plasma
0:01:37
Creative New Ways to Conduct Virtual Drug Discovery
0:10:13
e-Therapeutics: Accelerating drug discovery with a novel view of disease networks
0:48:16
How #AI and Machine Learning can accelerate drug discovery and development
0:08:15
SciAgents: Agentic AI for discovery, integrating knowledge graphs, LLMs & adversarial experts
0:55:03
HT-SPR Technology Across Discovery Platforms | Therapeutic Antibody Screening | Novel Therapeutics
0:04:18
Accelerating the discovery of future cures with Exscalate
0:19:53
Day 2: Novel Strategies for Biological Drug Development
0:01:43
Predict Novel Synthetic Reactions with CAS SciFinder Discovery Platform
0:05:09
Harnessing Generative AI for Accelerated Drug Discovery
0:37:04
Mo Jain - novel technologies for biomarker discovery
0:51:00
How to Accelerate the Rate Limiting Step in Drug Discovery, Synthesis of Target Molecules
1:26:02
Natural product antibiotics: from traditional screening to novel discovery approaches
0:08:34
How can AI help accelerate drug discovery?
0:10:02
Protein Homeostasis: Novel Strategies for Degenerative Diseases, Jeff Kelly, PhD
0:40:11
The Great Acceleration in the Design and Discovery of Novel Materials
0:59:13
Rapid Discovery! Accelerate drug discovery from hit ID to the clinic
0:57:11
Novel Peptide Hit Identification and Lead Generating Strategies for Drug Discovery
0:36:11
Improving Drug Discovery: A Molecular Understanding of Cell Receptors (Full)
0:15:33
Discovery and prioritization of novel antibodies using repertoire sequencing and the IGX Platform